Price movement over the last 24 hours
AbCellera Biologics Inc vs Quantum Computing Inc — how do they compare? AbCellera Biologics Inc trades at $7.17 (market cap $2.35B), while Quantum Computing Inc trades at $8.82 (market cap $1.96B). The key difference: AbCellera Biologics Inc is the larger of the two by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Quantum Computing Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | QUBT | |
|---|---|---|
Market Cap | $2.35B | $1.96B |
Sector | Health | Technology |
52-Week High | $8.12 | $24.62 |
52-Week Low | $2.78 | $6.31 |
Enterprise Value | $1.99B | $977.49M |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →